Today we bring you #ChedHER: a day full of live programming celebrating women who are changing the game. In each hour, we'll focus on a different theme and introduce a new guest co-host.
In Opening Bell, we highlight women in business and finance and then women entrepreneurs. Anjali Kumar, Cheddar's Chief People Officer and General Counsel, kicks off the day's coverage with Kristen Scholer.
We hear from Dia Simms, president of Combs Enterprises, about how she climbed the ladder and got to where she is today. Simms started as Sean Combs' assistant in 2005 and gradually worked her way up the ranks. At times, Simms oversaw Combs' liquor, entertainment, and clothing properties, and also played a big role in the creation and launch Ciroc Vodka.
We also talk to Whitney Casey, founder of the women's tech start-up Finery. Casey and her partner Brooklyn Decker just closed on a $5 million round of funding. Finery is the world's first automated online operating system for wardrobes. Casey discusses the challenges she faced trying to get male-dominated VC firms to invest in a female-focused tech company.
President Joe Biden and Chinese President Xi Jinping have discussed Taiwan, artificial intelligence and security issues in a call meant to demonstrate a return to regular leader-to-leader dialogue between the two powers.
April is Earth month, and while the green revolution might feel far away, the founder of climate VC Siam Capital says it’s on it’s way, and, even better: it won't cost you more.
From snow in April to heatwaves in December, it’s hard to plan a trip in a climate change world. Startup Sensible Weather thinks weather-based travel reimbursements are the solution.
Between corporate debt and the widening gap between ‘the haves and the have nots,’ there are reasons to be cautious about the economy, even with interest rate cuts on their way.
If the A.I. hype hasn’t given you enough of a reason to be excited (and a little terrified), the CEO of Zapata AI says the next frontier is designing bridges or creating pharmaceutical drugs.